Evolutionary Genomics, Inc. FNAM
We take great care to ensure that the data presented and summarized in this overview for EVOLUTIONARY GENOMICS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in FNAM
Top Purchases
Top Sells
About FNAM
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company develops Adapted Traits Platform, a technology platform to identify genes for enhancing crop plant traits, such as yield, sugar content, biomass, drought tolerance, and pest/disease resistance. It serves governmental organizations, non-profit foundations, and commercial entities. Evolutionary Genomics, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado.
Insider Transactions at FNAM
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2022
|
Virginia P. Orndorff Director |
SELL
Payment of exercise price or tax liability
|
Direct |
15,714
-11.29%
|
$0
$0.7 P/Share
|
|
May 23
2022
|
Virginia P. Orndorff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+13.94%
|
$0
$0.55 P/Share
|
|
May 23
2022
|
Steve B Warnecke Chairman, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
52,381
-2.77%
|
$0
$0.7 P/Share
|
|
May 23
2022
|
Steve B Warnecke Chairman, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
66,667
+3.49%
|
$0
$0.55 P/Share
|
|
May 23
2022
|
Walter Messier Secretary / Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
78,571
-30.15%
|
$0
$0.7 P/Share
|
|
May 23
2022
|
Walter Messier Secretary / Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+35.46%
|
$0
$0.55 P/Share
|
|
May 19
2021
|
Steve B Warnecke Chairman, CEO |
SELL
Bona fide gift
|
Direct |
75,000
-1.99%
|
-
|
|
Dec 30
2020
|
Steve B Warnecke Chairman, CEO |
SELL
Bona fide gift
|
Direct |
30,000
-0.78%
|
-
|